Twitxy Saved

Eric Smith

@ESmithMDPhD

Cell/Gene/RNA engineering to cure cancer @DanaFarber, @harvardmed, @broadinstitute, formerly @sloan_kettering, #CART
Boston, MA ericsmithlab.dana-farber.org Joined November 2014
922 Following 1.5K Followers 284 Posts

Latest posts 5

Pinned post

Eric Smith @ESmithMDPhD
Our report of first-in-human GPRC5D-targeted CAR T cells for MM is out in NEJM! The trial was led by Sham Mailankody and could not be done without the amazing clinical, correlative science, stats, & cell manufacturing teams.
Happy to share our bench>bedside journey
1/10
Eric Smith @ESmithMDPhD
So exciting to see the first clinical data of the dual- BCMA/GPRC5D CAR! Congrats D Hansen @MoffittNews, C Mo @DanaFarberNews, S Mailankody @MSKCancerCenter and all the clinical teams leading this study + K Harrington and @bmsnews cell tx teams. #ims26 #mmsm @fdezdelarrea
Multiple Myeloma Hub Verified account @MM_Hub Sep 26
CONGRESS | #IMS26 | PRESENTATION

Doris Hansen, Moffitt Cancer Center, presents initial findings from a phase I trial investigating BMS-986453 in patients with RRMM (N = 58).

Patients were administered 25, 75, 150 or 300 million (M) CAR T-cells. At median FU of 12 months, ORR was 83% for all doses. In patients who were BCMA/GPRC5D-naïve and treated with 75 or 15 million CAR T cells (n=16), ORR was 83%, and 100% achieved ≥VGPR and were MRD(−) at 10⁻⁵ threshold. Dose-limiting toxicities occurred in 19% of patients. Grade 3/4 TEAEs were reported in 98% of patients; neutropenia (88%) and thrombocytopenia (48%) were the most common.

Follow our live feed for more updates: bit.ly/4cWKNew

Intended for HCPs. This congress coverage is independently supported through funding from pharmaceutical companies. A full list of our funders can be found on our website. Funders are allowed no influence.

#MultipleMyeloma #myeloma #mmsm #MedEd #MedicalCongress @MoffittNews
View quoted post on X
1 replies 7 reposts 27 likes 2.2K views View on X
Eric Smith @ESmithMDPhD
Honored to be recognized w/ past + current Investigators @AhrensNicklas @AnguelaXavier & @DevermanLab. Award is to our entire @DanaFarber gene and cell therapy team & the huge teams of colleagues past/present who work to bring these therapies from ideas in the lab to patients.
Dana-Farber News Verified account @DanaFarberNews May 16, 2025
Congratulations to Eric Smith, MD, PhD, @DanaFarber on receiving the Outstanding New Investigator Award from @ASGCTherapy. Smith will present on advancing CAR T cell therapy for cancer immunotherapy. #ASGCT2025
View quoted post on X